CLGN
Collplant Biotechnologies
$0.32
+$0.00 (+1.27%)Jul 27, 2026
Key metrics
The numbers that frame CLGN today
- Market cap
- $4.60M
- P/E (TTM)
- -0.4
- EV / FCF
- -0.3
- Gross margin
- -147.6%
- EV / Sales
- 7.7
- ROIC
- -235.3%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $0.28
- 52wk High
- $3.23
Growth
Revenue and earnings trend for CLGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLGN
Is Collplant Biotechnologies a good buy?
No. Collplant Biotechnologies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Collplant Biotechnologies is selling at a very high price.
What is the market capitalization of CLGN?
Collplant Biotechnologies's market capitalization is $4.60M.
What is the P/E ratio for CLGN stock?
Collplant Biotechnologies's current P/E ratio is -0.4.
What is the 52-week high for CLGN stock?
The 52-week high for Collplant Biotechnologies is $3.23. The current close of $0.32 is 90.1% below that high.
What is the 52-week low for CLGN stock?
The 52-week low for Collplant Biotechnologies is $0.28. The current close of $0.32 is 16% above that low.
Does CLGN stock pay dividends?
Collplant Biotechnologies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLGN?
Collplant Biotechnologies's Debt / Equity ratio is 0.54.